Clinical Trial Update: Resolving Bile Reflux by Lanreotide in Patients With Roux-en-Y Gastrojejunostomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lanreotide to resolve bile reflux in patients with Roux-en-Y gastrojejunostomy. The trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Reflux Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Lanreotide (lanreotide)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Acid Reflux Esophagitis, Non-acid Reflux Esophagitis | Phase 2 | Status: UNKNOWN